1. Home
  2. RDW vs DNTH Comparison

RDW vs DNTH Comparison

Compare RDW & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDW

Redwire Corporation

HOLD

Current Price

$14.48

Market Cap

1.8B

Sector

Industrials

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$85.83

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
DNTH
Founded
2020
2015
Country
United States
United States
Employees
750
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
4.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RDW
DNTH
Price
$14.48
$85.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$13.71
$121.00
AVG Volume (30 Days)
26.3M
404.8K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,036,000.00
Revenue This Year
$41.68
N/A
Revenue Next Year
$20.25
$29.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$16.77
52 Week High
$22.25
$96.50

Technical Indicators

Market Signals
Indicator
RDW
DNTH
Relative Strength Index (RSI) 69.69 47.72
Support Level $7.63 $82.00
Resistance Level $14.55 $90.23
Average True Range (ATR) 1.14 4.60
MACD 0.50 -0.82
Stochastic Oscillator 95.32 38.68

Price Performance

Historical Comparison
RDW
DNTH

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: